Related Experiment Video
Updated: Jan 11, 2026

Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way
Published on: May 10, 2021
Margin Matters: Advances in Intraoperative Margin Assessment for Breast-Conserving Surgery
Valentin Ivanov1, Usman Khalid2, Rosen Dimov3
1Medical Simulation and Training Center, Medical Faculty, Medical University of Plovdiv, Department of Surgery, University Hospital "Kaspela", 4001 Plovdiv, Bulgaria.
Evaluating intraoperative margin assessment in breast-conserving surgery, this study reviews conventional and emerging techniques. New technologies show promise for reducing re-excisions and improving outcomes, but require further standardization and trials for widespread adoption.
Area of Science:
- Surgical Oncology
- Medical Imaging
- Biotechnology
Background:
- Breast cancer is the most common female neoplasm, with breast-conserving surgery increasingly preferred over mastectomy.
- Achieving negative margins while preserving glandular tissue in breast-conserving surgery remains a significant challenge.
- Traditional intraoperative margin assessment methods have limitations including time, interpretation, and operator dependency.
Purpose of the Study:
- To critically evaluate conventional and emerging intraoperative margin assessment techniques in breast-conserving surgery.
- To highlight the clinical utility, limitations, and potential of these techniques in reducing re-excision rates.
- To assess the impact on patient outcomes and cosmetic results.
Main Methods:
- Systematic literature review of PubMed and Google Scholar databases.
- Search terms included specimen radiography, intraoperative ultrasonography, mass spectrometry, optical coherence tomography, and artificial intelligence.
- Study selection based on relevance, language, completeness, and author consensus.
Main Results:
- Conventional techniques are valuable for reducing re-excisions and maintaining cosmetic outcomes.
- Emerging technologies like MarginProbe, fluorescence imaging, mass spectrometry, OCT, and AI-enhanced imaging offer real-time feedback and improved accuracy.
- Widespread adoption of emerging tools is hindered by cost, training requirements, and data variability.
Conclusions:
- Further investment in standardized protocols and multicenter trials is crucial for emerging technologies.
- Integrating imaging, spectroscopy, and AI presents a promising framework for enhancing surgical outcomes.
- Improved intraoperative margin assessment can lead to better quality of life for breast cancer patients.
More Related Videos
07:47Author Spotlight: 3D Scanning and Augmented Reality for Enhanced Cancer Surgery Communication
Published on: December 15, 2023
13:35Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024